Polymerase chain reaction is a laboratory technique used to copy a particular region of DNA. The main goal of PCR is to make enough copies of the targeted region of DNA so that the copies can be used for analysis. There are five core ingredients required to set up PCR namely DNA template, primers, DNA nucleotides, Taq polymerase, and buffer. PCR is very precise technique and can be used to amplify a specific short DNA strand in a mixture of DNA molecules. Before PCR, the DNA segments were amplified by using vectors in bacteria. This process took weeks to get the amplified DNA. As PCR is faster than this technique, PCR was readily accepted on the global level. PCR is also more efficient than the conventional techniques used for amplification.
The advancement in the technology of qPCR and dPCR leading to automation, improved accuracy, and enhanced sensitivity majorly drive the market growth. These products provide high level of efficiency and productivity in research and drug discovery and reduce the time required for the novel drug development. In addition, there is increased demand for polymerase chain reaction technologies owing to increase in number of hospitals and research centers. Furthermore, the increase in number of patients suffering from infectious diseases and rise in funding in gene therapy and human genome projects will also help to fuel the growth of the global polymerase chain reaction technologies market. Moreover, there is growth in demand for polymerase chain reaction technologies in the field of life science, clinical diagnostics, and others, which would further drive the market. However, growth of non-validated home brew test and unstable reimbursement policies are projected to hinder the growth of global polymerase chain reaction technologies market.
North America accounted for maximum contribution to the total revenue generated, owing to the rise in prevalence of infectious diseases and cancer in this region and technological advancement in PCR. However, Asia is projected to grow at the highest CAGR during the forecast period. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities.
In 2018, the global Polymerase Chain Reaction market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Polymerase Chain Reaction status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polymerase Chain Reaction development in United States, Europe and China.
The key players covered in this study
F. Hoffmann-La Roche
Thermo Fisher Scientific
Market segment by Type, the product can be split into
Market segment by Application, split into
Diagnostic Centers & Hospitals
Academic & Research Institutions
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Polymerase Chain Reaction status, future forecast, growth opportunity, key market and key players.
To present the Polymerase Chain Reaction development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Polymerase Chain Reaction are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.